The effect of polymethoxy flavonoid on a liver function,sugar,lipid metabolism and obesity.Randomized Control Trial - The study of effectiveness of Polymethoxy flavonoid

ARKRAY, Inc.0 个研究点目标入组 44 人开始时间: 2016年4月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Viral hepatitis patient, alcoholic hepatitis patient, autoimmune liver damage patient 2)BMI>=30 3)Heart failure, myocardial infarction with a history of the past of the treatment 4)Those who takes medicine for antihypertensive drug, lipidosis symptom therapeutic drug, diabetes therapeutic drug, livers 5)Those who are under treatment for atrial fibrillation, arrhythmia, a liver damage, a renal damage, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, high blood pressure 5)Those who suffer any severe disease diagnosised by the responsible doctor. 6) Those who drink more than 20 grams alcohol a day everyday (beer 500 ml or sake around 1 go) 7) Those who takes a supplement regularly. 8) Those who have food allergy. 9) Those who is in breast-feeding or pregnancy, or wishes to become pregnant during the study period. 10) Those who had participated in a clinical trial within 30 days before a screening test. 11) Those who is judged as ineligible by principal investigators or researchers.

发起方

ARKRAY, Inc.